Confirmation of MET amplification by fluorescence in situ hybridization (FISH) was performed only in samples with MET positivity on immunohistochemistry (2+ or 3+ staining intensity in >50.0% of the tumor cells according to the Metmab criteria[14]). This evidence concerns the gene MET and neoplasm.